Prevalence of Piperacillin-Tazobactam induced Hypersensitivity Reaction in Workers of Stallion’s Pharmaceutical Factory at Lahore

Anwar Ali Sulehri, Hafiz Muhammad Hammad Yaqub, Humayun Suqrat Hassan Imam, Uzma Sagheer, Muhammad Abubakar
{"title":"Prevalence of Piperacillin-Tazobactam induced Hypersensitivity Reaction in Workers of Stallion’s Pharmaceutical Factory at Lahore","authors":"Anwar Ali Sulehri, Hafiz Muhammad Hammad Yaqub, Humayun Suqrat Hassan Imam, Uzma Sagheer, Muhammad Abubakar","doi":"10.37723/jumdc.v13i4.718","DOIUrl":null,"url":null,"abstract":"BACKGROUND & OBJECTIVE: Piperacillin is an antibiotic that belongs to the ureidopenicillin family. Piperacillin-tazobactam provides cover against gram-positive, gram-negative bacteria and some bacteria of anaerobic nature. It is an extended-spectrum antibiotic and is used along with tazobactam which is an inhibitor of beta-lactamase. The main objective of our research was to identify the hypersensitivity reactions of piperacillin-tazobactam in pharmaceuticals factory and office workers. \nMETHODOLOGY: A Cross-sectional study was conducted at Stallion Pharmaceuticals (Pvt) Ltd located at Sundar Industrial Estate Lahore, Pakistan, from March to April 2018, after approval from the institutional research committee. All the workers, including factory workers and office workers at Stallion Pharmaceuticals (Pvt) Ltd were included in this study. Data was collected from each respondent by immediate-type skin testing. Data analysis was done by SPSS version 25, the demographic data was evaluated by descriptive statistics, Fisher Exact test was used for comparison and p≤0.05 was taken as significant. \nRESULTS: The results of the study presented that hypersensitivity reaction was present in (7.5%) of males and (3.8%) of females. It was also observed that (8.8%) of factory workers had hypersensitivity reactions when they are gone through skin tests, and only (2.5%) of office workers were skin test positive. From the above results (11.2%) of all the respondents developed hypersensitivity reactions and (88.8%) showed no reaction when they were gone through skin tests, which contain 0.1 ml of piperacillin and tazobactam. Fisher exact test was applied, and results showed no significant difference between hypersensitivity reactions among factory and office workers as the p-value was 01. \nCONCLUSION: Hypersensitivity reaction to piperacillin-tazobactam was minimal in the factory & office workers, and this was not significant.","PeriodicalId":178216,"journal":{"name":"Journal of University Medical & Dental College","volume":"50 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of University Medical & Dental College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37723/jumdc.v13i4.718","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND & OBJECTIVE: Piperacillin is an antibiotic that belongs to the ureidopenicillin family. Piperacillin-tazobactam provides cover against gram-positive, gram-negative bacteria and some bacteria of anaerobic nature. It is an extended-spectrum antibiotic and is used along with tazobactam which is an inhibitor of beta-lactamase. The main objective of our research was to identify the hypersensitivity reactions of piperacillin-tazobactam in pharmaceuticals factory and office workers. METHODOLOGY: A Cross-sectional study was conducted at Stallion Pharmaceuticals (Pvt) Ltd located at Sundar Industrial Estate Lahore, Pakistan, from March to April 2018, after approval from the institutional research committee. All the workers, including factory workers and office workers at Stallion Pharmaceuticals (Pvt) Ltd were included in this study. Data was collected from each respondent by immediate-type skin testing. Data analysis was done by SPSS version 25, the demographic data was evaluated by descriptive statistics, Fisher Exact test was used for comparison and p≤0.05 was taken as significant. RESULTS: The results of the study presented that hypersensitivity reaction was present in (7.5%) of males and (3.8%) of females. It was also observed that (8.8%) of factory workers had hypersensitivity reactions when they are gone through skin tests, and only (2.5%) of office workers were skin test positive. From the above results (11.2%) of all the respondents developed hypersensitivity reactions and (88.8%) showed no reaction when they were gone through skin tests, which contain 0.1 ml of piperacillin and tazobactam. Fisher exact test was applied, and results showed no significant difference between hypersensitivity reactions among factory and office workers as the p-value was 01. CONCLUSION: Hypersensitivity reaction to piperacillin-tazobactam was minimal in the factory & office workers, and this was not significant.
拉合尔马制药厂工人哌拉西林-他唑巴坦致过敏反应的流行情况
背景与目的:哌拉西林是一种属于脲霉素家族的抗生素。哌拉西林-他唑巴坦提供了对革兰氏阳性、革兰氏阴性细菌和一些厌氧细菌的保护。它是一种广谱抗生素,与他唑巴坦一起使用,他唑巴坦是一种内酰胺酶抑制剂。本研究的主要目的是确定哌拉西林-他唑巴坦在制药厂和办公室工作人员中的超敏反应。方法:经机构研究委员会批准,于2018年3月至4月在位于巴基斯坦拉合尔Sundar工业区的Stallion Pharmaceuticals (Pvt) Ltd进行了一项横断面研究。本研究以马马制药(私人)有限公司所有工人为研究对象,包括工厂工人和办公室工人。通过即时型皮肤测试收集每个应答者的数据。数据分析采用SPSS 25,人口统计学资料采用描述性统计,比较采用Fisher精确检验,以p≤0.05为差异有统计学意义。结果:研究结果显示,男性(7.5%)和女性(3.8%)存在超敏反应。还观察到(8.8%)的工厂工人在进行皮肤试验时出现过敏反应,只有(2.5%)的办公室工作人员皮肤试验呈阳性。从上述结果看,所有应答者(11.2%)出现超敏反应,(88.8%)在进行含有0.1 ml哌拉西林和他唑巴坦的皮肤试验时没有反应。采用Fisher精确检验,结果显示工厂员工和办公室员工的超敏反应无显著差异,p值为01。结论:工厂和办公室工作人员对哌拉西林-他唑巴坦的超敏反应最小,且不显著。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信